Happel David Insider Trades

Insider Trading History

Track insider trading activity for Happel David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $5.53M 805,621 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 384,000 shares
$5.38
$6.86
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $4.65M 677,621 shares
Last Trade
Feb 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$64.9k 12,101 shares
$5.36
$6.86
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $4.73M 689,722 shares
Last Trade
Jul 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$598k 65,478 shares
$9.13
$6.86
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $5.18M 755,200 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 472,000 shares
$4.71
$6.86
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $4.38M 639,200 shares
Last Trade
Mar 26, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$63.8k 12,100 shares
$5.27
$6.86
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $4.3M 627,100 shares
Last Trade
Dec 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.56k 1,600 shares
$4.10
$6.86
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $4.29M 625,500 shares
Last Trade
Nov 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.85M 624,910 shares
$2.96
$6.86
Sagimet Biosciences
Sagimet Biosciences SGMT
President & CEO
Holding Value $4.05k 590 shares
Last Trade
Nov 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.39k 590 shares
$2.35
$6.86
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Commercial Dev & Strategy
Holding Value $2.77M 23,860 shares
Last Trade
Oct 25, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 7,953 shares
$13.53
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Commercial Dev & Strategy
Holding Value $1.07M 9,239 shares
Last Trade
Oct 25, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 7,953 shares
$13.53
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Commercial Dev & Strategy
Holding Value $592k 5,089 shares
Last Trade
Oct 25, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$56.1k 4,150 shares
$13.53
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP Global Orphan Bus. Unit
Holding Value $0 0 shares
Last Trade
Nov 04, 2016 Sale
$1.24M 82,487 shares
$15.05
$116.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up